CTRI/2020/07/026277尚未招募未知
: Serum Tissue plasminogen activator (t-PA:Ag)levels in patients withDiabetic foot infections.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All Patients of Diabetic foot infection irrespective of the Wagnerâ??s stage will be included of age more than 18 years.
排除标准
- •i.Pregnancy
- •ii.Use of antiplatelet agents or fibrinolytic drugs
- •iii.Cerebral stroke in the previous 6 months that was treated with thrombolysis
- •iv.Myocardial infarction within the last year.
研究者
相似试验
已完成
不适用
Recombinant tissue Plasminogen Activator administration by retinal branch vein route for Central Retinal Vein Occlusion: a randomised conventional therapy controlled trialCentral Retinal Vein Occlusion (CRVO)Eye DiseasesISRCTN58543190Oogziekenhuis Rotterdam (OZR) (The Netherlands)48
招募中
3 期
The role of anticoagulant and thrombolitic in treatment of COVID patientsCOVID 19.COVID-19, virus identifiedU07.1IRCT20200515047456N1Tabriz University of Medical Sciences15
已完成
3 期
tissue type plasminogen activator(t-PA) and Edaravon combination therapy studyAcute ischemic strokeJPRN-UMIN000006330eurology, Nippon Medical School200
进行中（未招募）
1 期
A clinical trial of a clot dissolving drug and gas, injected into the eye, to treat bleeding associated with wet age-related macular degeneratioSub-macular haemorrhage secondary to wet macular degenerationMedDRA version: 16.0Level: PTClassification code 10064930Term: Age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 16.0Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersEUCTR2012-004078-24-GBKing's College London
已完成
2 期
Effect of treatment with tissue plasminogen activator in improving clinical status of patients with acute ischemic strokeIRCT201709049014N182Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences40